Rapidly Progressive Dementia with Asymmetric Rigidity Following ChAdOx1 nCoV-19 Vaccination

Department of Geriatric Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi, UP, India. Department of Neurology, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India. Department of Geriatric Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi, UP, India. Department of Pharmacology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, UP, India. Department of Radiodiagnosis and Imaging, Institute of Medical Sciences, Banaras Hindu University, Varanasi, UP, India. Department of Radiology, Maharishi Markandeshwar (deemed to be) University, Mullana, Haryana, India. Department of Geriatric Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi, UP, India. Department of Pharmacology and Neuroscience, University of North Texas Health Science Center, Fort Worth, Texas, USA. Department of Biochemistry and Central Research Cell, Maharishi Markandeshwar (deemed to be) University, Mullana, Haryana, India

[1]  Stefania Perna,et al.  Effectiveness of COVID-19 vaccines and their challenges (Review) , 2021, Experimental and therapeutic medicine.

[2]  R. Bakshi,et al.  COVID-19 mRNA vaccination leading to CNS inflammation: a case series , 2021, Journal of Neurology.

[3]  H. Mangat,et al.  Guillain‐Barré Syndrome following ChAdOx1‐S/nCoV‐19 Vaccine , 2021, Annals of neurology.

[4]  Fridtjof Lund-Johansen,et al.  Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination , 2021, The New England journal of medicine.

[5]  Cao Chen,et al.  Impact of COVID-19 Pandemic on Patients With Neurodegenerative Diseases , 2021, Frontiers in Aging Neuroscience.

[6]  Ashutosh Kumar Singh,et al.  A prospective observational safety study on ChAdOx1 nCoV-19 corona virus vaccine (recombinant) use in healthcare workers- first results from India , 2021, EClinicalMedicine.

[7]  Danish Idrees,et al.  SARS-CoV-2 spike protein interactions with amyloidogenic proteins: Potential clues to neurodegeneration , 2021, Biochemical and Biophysical Research Communications.

[8]  M. Talebi,et al.  Is there a link between COVID-19 and Creutzfeldt-Jakob Disease? a Case Report , 2021 .

[9]  M. Locci,et al.  SARS-CoV-2 mRNA Vaccines: Immunological Mechanism and Beyond , 2021, Vaccines.

[10]  A. Cagigi,et al.  Immune Responses Induced by mRNA Vaccination in Mice, Monkeys and Humans , 2021, Vaccines.

[11]  A. Vojdani,et al.  Reaction of Human Monoclonal Antibodies to SARS-CoV-2 Proteins With Tissue Antigens: Implications for Autoimmune Diseases , 2021, Frontiers in Immunology.

[12]  I. Tavassoly,et al.  Seeding Brain Protein Aggregation by SARS-CoV-2 as a Possible Long-Term Complication of COVID-19 Infection. , 2020, ACS chemical neuroscience.

[13]  Xiaohong Song,et al.  A single dose of an adenovirus-vectored vaccine provides protection against SARS-CoV-2 challenge , 2020, Nature Communications.

[14]  V. Munster,et al.  ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques , 2020, Nature.

[15]  J. Schmahmann,et al.  Creutzfeldt-Jakob disease in a man with COVID-19: SARS-CoV-2-accelerated neurodegeneration? , 2020, Brain, Behavior, and Immunity.

[16]  G. Tetz,et al.  SARS-CoV-2 Prion-Like Domains in Spike Proteins Enables Higher Affinity to ACE2 , 2020 .

[17]  Kimberly J. Hassett,et al.  Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses , 2017, Molecular therapy : the journal of the American Society of Gene Therapy.

[18]  D. Weissman,et al.  Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes. , 2015, Journal of controlled release : official journal of the Controlled Release Society.